Clinical use of nitrous oxide could help treat depression
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, say researchers from BHP members th…
Birmingham researchers lead world-first treatment trial for rare liver disease
The first participant has been treated in an early-phase clinical trial investigating whether a new medical device, Carbalive, can slow disease progression and improve outcomes for patients with a ra…
Lifesaving programme to prevent post-birth bleeding wins Times Higher Education STEM Award
A cost-effective intervention for postpartum haemorrhage, which has reduced maternal deaths worldwide by 60%, has won a major award in UK Higher Education.
The E-MOTIVE programme led by BHP founde…
DaRe2THINK launches enhanced digital platform to transform clinical trials for GP practices
A new digital platform has been launched to transform how NHS GP practices take part in clinical trials, making research quicker, easier and more inclusive for patients across the UK.
The DaRe2THI…
A year of growth, innovation and partnership
Following a year in which Birmingham Health Partners organisations won more than £70m of research investments from NIHR and other funders, signed a strategic partnership with ABHI, and launched its B…
Professor Andrew Filer appointed Director of NIHR Birmingham Biomedical Research Centre
The National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC) has announced the appointment of Professor Andrew Filer as its new Director. Professor Filer tak…